Investor Relations Event
AI summary · Not investment advice
Neoimmunetech will hold an IR presentation and Q&A for domestic analysts and institutional investors in Yeouido, Seoul, on November 4-5.
Key facts
- IR period
- Nov 4, 2026Start date 2026-11-04, end date 2026-11-05
- Venue
- Yeouido, Seoul
- Audience
- Domestic brokerage analysts and institutional investors, etc.
- Purpose
- Improve understanding of development status and management strategy
- Format
- Presentation and Q&A
- Main topics
- Explanation of R&D progress; explanation of technology transfer and Endari business progress, and Q&A
- Sponsor
- IR Curdus
- Materials posting date
- Nov 4, 2026
- Materials location
- Posted in the IR library of the KRX KIND system (https://kind.co.kr)
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
N